US FDA expands J&J’s psoriasis drug
THE US Food and Drug Administration has allowed the expanded use of Johnson & Johnson’s drug, Tremfya, to treat adults with a type of chronic inflammatory bowel disease, the company said on Wednesday. The approval […]